Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Collegium Pharmaceutical (COLL) Receivables - Other (2024 - 2025)

Collegium Pharmaceutical has reported Receivables - Other over the past 2 years, most recently at $19.8 million for Q4 2025.

  • Quarterly results put Receivables - Other at $19.8 million for Q4 2025, down 20.6% from a year ago — trailing twelve months through Dec 2025 was $19.8 million (down 20.6% YoY), and the annual figure for FY2025 was $19.8 million, down 20.6%.
  • Receivables - Other for Q4 2025 was $19.8 million at Collegium Pharmaceutical, down from $25.0 million in the prior quarter.
  • Over the last five years, Receivables - Other for COLL hit a ceiling of $25.0 million in Q4 2024 and a floor of $19.8 million in Q4 2025.